Risk score for early mortality to stratify for intensive SSc therapy in the EUSTAR network: the RESIST score

Annals of the Rheumatic Diseases 2026 Open access

Read full text
Authors: Ann‐Christin Pecher, Marouane Boubaya, Yannick Allanore, Vanessa Smith, JK de Vries-Bouwstra, Radim Bečvář, Gianluca Moroncini, David Launay, Maria De Santis, Kamal Solanki, Carlomaurizio Montecucco, Luca Idolazzi
+8 more Fathi Nihal, Kotyla Przemyslaw, Marie-Elise Truchetet, Masataka Kuwana, Francesco Del Gado, Oliver Distler, Muriel Elhaï, Jörg Henes
DOI: 10.1016/j.ard.2026.01.016
Cited by: 6
References: 33

Abstract

OBJECTIVES: Systemic sclerosis (SSc) is associated with increased mortality. Intensive therapies have emerged for severe or refractory cases, but carry significant risks. The Risk score for Early mortality to Stratify for Intensive SSc Therapy (RESIST) score was developed to predict early mortality (55 years; elevated C-reactive protein; digital ulcers; modified Rodnan skin score >14; left ventricular ejection fraction

Fields of Study & Subjects

Sepsis Diagnosis and Treatment Cardiac Anesthesia and Surgical Outcomes Congenital Heart Disease Studies

Publication details

Journal / source
Annals of the Rheumatic Diseases
Publisher
Elsevier BV
Volume
85
Issue
6
Pages
1163–1171
Publication date
16 March 2026
Language
EN